Evidence map›Paper›PMID 38399969›Full record

ArticleViruses2024

HIV-1 Reverse Transcriptase Expression in HPV16-Infected Epidermoid Carcinoma Cells Alters E6 Expression and Cellular Metabolism, and Induces a Hybrid Epithelial/Mesenchymal Cell Phenotype.

Alla Zhitkevich, Ekaterina Bayurova, Darya Avdoshina, Natalia Zakirova, Galina Frolova, Sona Chowdhury, Alexander Ivanov, Ilya Gordeychuk, Joel M Palefsky, Maria Isaguliants

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Viral oncogenesis in cancer: from mechanisms to therapeutics.Signal transduction and targeted therapy · 2025
    Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Alla ZhitkevichChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0003-3993-6909
Ekaterina BayurovaChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0002-6160-2203
Darya AvdoshinaChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0001-8168-5969
Natalia ZakirovaCentre for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, 119991 Moscow, Russia.
Galina FrolovaChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 119991 Moscow, Russia.
Sona ChowdhuryDivision of Infectious Diseases, Department of Medicine, University of California, San Francisco, CA 94143, USA.
Alexander IvanovGamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.ORCID 0000-0002-5659-9679
Ilya GordeychukChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0002-4551-7535
Joel M PalefskyDivision of Infectious Diseases, Department of Medicine, University of California, San Francisco, CA 94143, USA.
Maria IsaguliantsDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.ORCID 0000-0001-9382-2254
Russian Academy of Sciences · RUEngelhardt Institute of Molecular Biology · RUUniversity of California, San Francisco · USKarolinska Institutet · SE

Funding

New therapeutic HPV vaccines for HIV infected men and womenR01CA217715 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PALEFSKY, JOEL MICHAEL · 2017 to 2019
$594k
NCI NIH HHS R01 CA217715
6 · The paper itself

Abstract

The high incidence of epithelial malignancies in HIV-1 infected individuals is associated with co-infection with oncogenic viruses, such as high-risk human papillomaviruses (HR HPVs), mostly HPV16. The molecular mechanisms underlying the HIV-1-associated increase in epithelial malignancies are not fully understood. A collaboration between HIV-1 and HR HPVs in the malignant transformation of epithelial cells has long been anticipated. Here, we delineated the effects of HIV-1 reverse transcriptase on the in vitro and in vivo properties of HPV16-infected cervical cancer cells. A human cervical carcinoma cell line infected with HPV16 (Ca Ski) was made to express HIV-1 reverse transcriptase (RT) by lentiviral transduction. The levels of the mRNA of the E6 isoforms and of the factors characteristic to the epithelial/mesenchymal transition were assessed by real-time RT-PCR. The parameters of glycolysis and mitochondrial respiration were determined using Seahorse technology. RT expressing Ca Ski subclones were assessed for the capacity to form tumors in nude mice. RT expression increased the expression of the E6*I isoform, modulated the expression of

Indexed as

Carcinoma, Squamous CellHIV Reverse TranscriptaseHuman papillomavirus 16Oncogene Proteins, ViralUterine Cervical NeoplasmsAnimalsEpithelial CellsFemaleHumansMiceMice, NudePapillomavirus E7 ProteinsPhenotypeRepressor ProteinsE6 protein, Human papillomavirus type 16HIV Reverse TranscriptaseOncogene Proteins, ViralPapillomavirus E7 ProteinsRepressor Proteinsreverse transcriptase, Human immunodeficiency virus 1E6*I isoform expressionglycolysisHIV-1HPV16-positive cellsmitochondrial respirationreverse transcriptase

Identifiers

PMID38399969
PMCPMC10892743
OpenAlexW4391263198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.